Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M212892200 on April 13, 2003

J. Biol. Chem., Vol. 278, Issue 26, 23738-23746, June 27, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/26/23738    most recent
M212892200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wyse, B. D.
Right arrow Articles by Hancock, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wyse, B. D.
Right arrow Articles by Hancock, J. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Caveolin Interacts with the Angiotensin II Type 1 Receptor during Exocytic Transport but Not at the Plasma Membrane*

Bruce D. Wyse {ddagger} §, Ian A. Prior {ddagger} §, Hongwei Qian ¶, Isabel C. Morrow {ddagger} ||, Susan Nixon {ddagger} ||, Cornelia Muncke {ddagger} §, Teymuras V. Kurzchalia **, Walter G. Thomas ¶, Robert G. Parton {ddagger} || and John F. Hancock {ddagger} § {ddagger}{ddagger}

From the {ddagger}Institute for Molecular Bioscience, the §Department of Molecular and Cellular Pathology, and the ||Centre for Microscopy and Microanalysis and School of Biomedical Sciences, University of Queensland, Brisbane, 4072 Queensland, Australia, the Baker Heart Research Institute, Melbourne, 3004 Victoria, Australia, and the **Max Planck Institute for Molecular Cell Biology and Genetics, Dresden D-01307, Germany

The mechanisms involved in angiotensin II type 1 receptor (AT1-R) trafficking and membrane localization are largely unknown. In this study, we examined the role of caveolin in these processes. Electron microscopy of plasma membrane sheets shows that the AT1-R is not concentrated in caveolae but is clustered in cholesterol-independent microdomains; upon activation, it partially redistributes to lipid rafts. Despite the lack of AT1-R in caveolae, AT1-R·caveolin complexes are readily detectable in cells co-expressing both proteins. This interaction requires an intact caveolin scaffolding domain because mutant caveolins that lack a functional caveolin scaffolding domain do not interact with AT1-R. Expression of an N-terminally truncated caveolin-3, CavDGV, that localizes to lipid bodies, or a point mutant, Cav3-P104L, that accumulates in the Golgi mislocalizes AT1-R to lipid bodies and Golgi, respectively. Mislocalization results in aberrant maturation and surface expression of AT1-R, effects that are not reversed by supplementing cells with cholesterol. Similarly mutation of aromatic residues in the caveolin-binding site abrogates AT1-R cell surface expression. In cells lacking caveolin-1 or caveolin-3, AT1-R does not traffic to the cell surface unless caveolin is ectopically expressed. This observation is recapitulated in caveolin-1 null mice that have a 55% reduction in renal AT1-R levels compared with controls. Taken together our results indicate that a direct interaction with caveolin is required to traffic the AT1-R through the exocytic pathway, but this does not result in AT1-R sequestration in caveolae. Caveolin therefore acts as a molecular chaperone rather than a plasma membrane scaffold for AT1-R.


Received for publication, December 18, 2002 , and in revised form, April 8, 2003.

* This work is supported by grants from the National Health and Medical Research Council of Australia (to J. F. H. and R. G. P.) and Queensland Cancer Fund (to J. F. H.). The Institute for Molecular Bioscience is a Special Research Center of the Australian Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger}{ddagger} To whom correspondence should be addressed. Tel.: 61-7-3346-2033; Fax: 61-7-3346-2101; E-mail: j.hancock{at}mailbox.uq.edu.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Fujita, J. Cheng, K. Tauchi-Sato, T. Takenawa, and T. Fujimoto
A distinct pool of phosphatidylinositol 4,5-bisphosphate in caveolae revealed by a nanoscale labeling technique
PNAS, June 9, 2009; 106(23): 9256 - 9261.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
Y. Xu, R. H. Henning, M. Sandovici, J. J. van der Want, W. H. van Gilst, and H. Buikema
Enhanced myogenic constriction of mesenteric artery in heart failure relates to decreased smooth muscle cell caveolae numbers and altered AT1- and epidermal growth factor-receptor function
Eur J Heart Fail, March 1, 2009; 11(3): 246 - 255.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. T. Nagami, J. A. Chang, M. E. Plato, and R. Santamaria
Acid loading in vivo and low pH in culture increase angiotensin receptor expression: enhanced ammoniagenic response to angiotensin II
Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1864 - F1870.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Fekete, K. Rosta, L. Wagner, A. Prokai, P. Degrell, E. Ruzicska, E. Vegh, M. Toth, K. Ronai, K. Rusai, et al.
Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney - another reason for diabetic nephropathy?
J. Physiol., November 15, 2008; 586(22): 5337 - 5348.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. Szaszak, H.-D. Chen, H.-C. Chen, A. Baukal, L. Hunyady, and K. J Catt
Identification of the invariant chain (CD74) as an angiotensin AGTR1-interacting protein
J. Endocrinol., November 1, 2008; 199(2): 165 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Hernandez-Deviez, M. T. Howes, S. H. Laval, K. Bushby, J. F. Hancock, and R. G. Parton
Caveolin Regulates Endocytosis of the Muscle Repair Protein, Dysferlin
J. Biol. Chem., March 7, 2008; 283(10): 6476 - 6488.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. P. McEwen, Q. Li, S. Jackson, P. M. Jenkins, and J. R. Martens
Caveolin Regulates Kv1.5 Trafficking to Cholesterol-Rich Membrane Microdomains
Mol. Pharmacol., March 1, 2008; 73(3): 678 - 685.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Langlois, K. N. Cowan, Q. Shao, B. J. Cowan, and D. W. Laird
Caveolin-1 and -2 Interact with Connexin43 and Regulate Gap Junctional Intercellular Communication in Keratinocytes
Mol. Biol. Cell, March 1, 2008; 19(3): 912 - 928.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Alioua, R. Lu, Y. Kumar, M. Eghbali, P. Kundu, L. Toro, and E. Stefani
Slo1 Caveolin-binding Motif, a Mechanism of Caveolin-1-Slo1 Interaction Regulating Slo1 Surface Expression
J. Biol. Chem., February 22, 2008; 283(8): 4808 - 4817.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Mendez-Bolaina, J. Sanchez-Gonzalez, I. Ramirez-Sanchez, E. Ocharan-Hernandez, M. Nunez-Sanchez, E. Meaney-Mendiolea, A. Meaney, J. Asbun-Bojalil, A. Miliar-Garcia, I. Olivares-Corichi, et al.
Effect of caveolin-1 scaffolding peptide and 17 -estradiol on intracellular Ca2+ kinetics evoked by angiotensin II in human vascular smooth muscle cells
Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1953 - C1961.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. M. C. Kong, A. Hasbi, M. Mattocks, T. Fan, B. F. O'Dowd, and S. R. George
Regulation of D1 Dopamine Receptor Trafficking and Signaling by Caveolin-1
Mol. Pharmacol., November 1, 2007; 72(5): 1157 - 1170.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. I. Gonzalez, E. Krizman-Genda, and M. B. Robinson
Caveolin-1 Regulates the Delivery and Endocytosis of the Glutamate Transporter, Excitatory Amino Acid Carrier 1
J. Biol. Chem., October 12, 2007; 282(41): 29855 - 29865.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. E. Linder, K. M. Thakali, J. M. Thompson, S. W. Watts, R. C. Webb, and R. Leite
Methyl-beta-cyclodextrin Prevents Angiotensin II-Induced Tachyphylactic Contractile Responses in Rat Aorta
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 78 - 84.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Shmuel, E. Nodel-Berner, T. Hyman, A. Rouvinski, and Y. Altschuler
Caveolin 2 Regulates Endocytosis and Trafficking of the M1 Muscarinic Receptor in MDCK Epithelial Cells
Mol. Biol. Cell, May 1, 2007; 18(5): 1570 - 1585.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. A. Syme, L. Zhang, and A. Bisello
Caveolin-1 Regulates Cellular Trafficking and Function of the Glucagon-Like Peptide 1 Receptor
Mol. Endocrinol., December 1, 2006; 20(12): 3400 - 3411.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Ushio-Fukai and R. W. Alexander
Caveolin-Dependent Angiotensin II Type 1 Receptor Signaling in Vascular Smooth Muscle
Hypertension, November 1, 2006; 48(5): 797 - 803.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. T. Drake, S. K. Shenoy, and R. J. Lefkowitz
Trafficking of G Protein-Coupled Receptors
Circ. Res., September 15, 2006; 99(6): 570 - 582.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. Kilianova, N. Basora, P. Kilian, M. D. Payet, and N. Gallo-Payet
Human Melanocortin Receptor 2 Expression and Functionality: Effects of Protein Kinase A and Protein Kinase C on Desensitization and Internalization
Endocrinology, May 1, 2006; 147(5): 2325 - 2337.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Martin
Caveolae and cell swelling. Focus on "Stimulation by caveolin-1 of the hypotonicity-induced release of taurine and ATP at basolateral, but not apical, membrane of Caco-2 cells"
Am J Physiol Cell Physiol, May 1, 2006; 290(5): C1273 - C1274.
[Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. G. Parton, M. Hanzal-Bayer, and J. F. Hancock
Biogenesis of caveolae: a structural model for caveolin-induced domain formation.
J. Cell Sci., March 1, 2006; 119(Pt 5): 787 - 796.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. C. Mora, V. L. Bonilha, B.-C. Shin, J. Hu, L. Cohen-Gould, D. Bok, and E. Rodriguez-Boulan
Bipolar assembly of caveolae in retinal pigment epithelium
Am J Physiol Cell Physiol, March 1, 2006; 290(3): C832 - C843.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. J. Hernandez-Deviez, S. Martin, S. H. Laval, H. P. Lo, S. T. Cooper, K. N. North, K. Bushby, and R. G. Parton
Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3
Hum. Mol. Genet., January 1, 2006; 15(1): 129 - 142.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Manninen, P. Verkade, S. Le Lay, J. Torkko, M. Kasper, J. Fullekrug, and K. Simons
Caveolin-1 Is Not Essential for Biosynthetic Apical Membrane Transport
Mol. Cell. Biol., November 15, 2005; 25(22): 10087 - 10096.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J.-P. Gratton, P. Bernatchez, and W. C. Sessa
Caveolae and Caveolins in the Cardiovascular System
Circ. Res., June 11, 2004; 94(11): 1408 - 1417.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. M. Attia, O. Feron, R. Goldschmeding, L. H. Radermakers, N. D. Vaziri, P. Boer, J.-L. Balligand, H. A. Koomans, and J. A. Joles
Hypercholesterolemia in Rats Induces Podocyte Stress and Decreases Renal Cortical Nitric Oxide Synthesis via an Angiotensin II Type 1 Receptor-Sensitive Mechanism
J. Am. Soc. Nephrol., April 1, 2004; 15(4): 949 - 957.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement